KEY KeyCorp tops Q1 2026 earnings estimates and posts 657 percent annual revenue growth while shares dip slightly DBRGH DigBridge H Series H yield draws income investors despite limited quarterly disclosure parent DigitalBridge reports results Is Celularity CELU a value trap or a value play Recovers 20260508 Kimco KIM Future Outlook Q4 2025 Earnings Beat Estimates Northrop Grumman Corporation NOC Q1 2026 Earnings Beat Aligns With Broader Defense Aerospace Sector Strength iShares MSCI Canada ETF EWC NearTerm Tariff Relief Offset by Persistent USMCA Review Overhang Materials Select Sector SPDR ETF XLB Positioned for Upside Amid BroadBased SP 500 Earnings Expansion How CXApp Warr CXAIW cash flow tells the real story Smart Money Exits 20260508 DeepSeek Fears Overblown Why US AI Titans May Weather the Storm New Fed Chair Appointment Announced Market Implications and Policy Outlook SP 500 Surpasses 7500 Milestone Tech Stocks in Focus Jasper Therapeutics JSPR Q1 2026 Beat Revenue NA EPS Exceeds by Significant Walmarts NonRetail Arm Emerges as Growth Engine but Premium Valuation Demands Proof Warren Buffetts Tiny Purchase Hint in March May Be Confirmed by Latest Berkshire Filing CVS Health Price Target Raised by 8 at Mizuho as Analyst Sees Potential Upside Kevin Warshs Potential Fed Regime Change Could Reshape Wall Streets Market Plumbing Chip Stocks Pare Recent Gains Oil Prices Slip on Mideast Deal Hopes Proposed Bank Acquisitions Surface in Illinois Market Theriva Biologics TOVX Q1 2026 Earnings Narrowed Loss Beats Expectations as Stock Rises Heritage Financial Corporation Q1 2026 Earnings EPS Beats Estimates by 343 Amid Steady Operations Definitive Healthcare Corp DH Q1 2026 Earnings EPS Surge Beats Expectations Stock Climbs ASX Q1 2026 Earnings EPS Surpasses Estimates by 9 Stock Rises VNT Q1 2026 Earnings EPS Misses Estimates by a Hair Stock Edges Higher EXLS Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Pending KT Corporation KT Declines 297 Amidst Broader Market Pressure Xos Inc XOS Holds Steady at 210 Key Support and Resistance in Focus Neumora Therapeutics NMRA Stock Holds Steady at 185 as Key Support and Resistance Levels Tighten Niagen Bioscience Inc NAGE Retreats 343 as Shares Approach Key Support Babcock Wilcox 2026 Notes BWNB Edge Lower Amid Quiet Trading Jim Cramer Warns Against ShortTerm Gains Highlights 3 Key Retirement Assets ETR Q1 2026 Earnings Slight EPS Miss Amid Solid Utility Performance Galectin Therapeutics Slips 3 as Stock Nears Key 257 Support Level